Posted On: 08/11/2016 11:21:44 PM
Post# of 30038
I do call out some posts as "delusional." For example, when the CEO says ESS is worth around $100M and Redspeed make claims that is worth $1.8B.
Regenicin was never valued that high. It went public and immediately tanked in value. I owned it.
That $1.8B number is puffery from a contingency fee lawyer's complaint.
Regenicin was never valued that high. It went public and immediately tanked in value. I owned it.
That $1.8B number is puffery from a contingency fee lawyer's complaint.
Quote:
ESS was tied up in a $1.643B lawsuit for years until Amarantus unraveled it, but there are folks that would like people to believe it's worthless. Regenicin, the previous owners, were valued at $1.8B before the litigation and a lot of positive events have happened since then. Get this into trial again and value will come back quickly as it's already been proven to work.
(6)
(0)Scroll down for more posts ▼
